Zucchi R - Search Results

1

Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3-iodothyronamine.

Selen Alpergin ES, Bolandnazar Z, Sabatini M, Rogowski M, Chiellini G, Zucchi R, Assadi-Porter FM. Selen Alpergin ES, et al. Among authors: zucchi r. Physiol Rep. 2017 Jan;5(1):e13097. doi: 10.14814/phy2.13097. Physiol Rep. 2017. PMID: 28082426 Free PMC article.

2

Metabolic Reprogramming by 3-Iodothyronamine (T1AM): A New Perspective to Reverse Obesity through Co-Regulation of Sirtuin 4 and 6 Expression.

Assadi-Porter FM, Reiland H, Sabatini M, Lorenzini L, Carnicelli V, Rogowski M, Selen Alpergin ES, Tonelli M, Ghelardoni S, Saba A, Zucchi R, Chiellini G. Assadi-Porter FM, et al. Among authors: zucchi r. Int J Mol Sci. 2018 May 22;19(5):1535. doi: 10.3390/ijms19051535. Int J Mol Sci. 2018. PMID: 29786646 Free PMC article.

3

NMR-based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T(1)AM treatment.

Haviland JA, Reiland H, Butz DE, Tonelli M, Porter WP, Zucchi R, Scanlan TS, Chiellini G, Assadi-Porter FM. Haviland JA, et al. Among authors: zucchi r. Obesity (Silver Spring). 2013 Dec;21(12):2538-44. doi: 10.1002/oby.20391. Epub 2013 May 29. Obesity (Silver Spring). 2013. PMID: 23512955 Free PMC article.

4

Uptake and metabolic effects of 3-iodothyronamine in hepatocytes.

Ghelardoni S, Chiellini G, Frascarelli S, Saba A, Zucchi R. Ghelardoni S, et al. Among authors: zucchi r. J Endocrinol. 2014 Mar 13;221(1):101-10. doi: 10.1530/JOE-13-0311. Print 2014 Apr. J Endocrinol. 2014. PMID: 24627446

5

Update on 3-iodothyronamine and its neurological and metabolic actions.

Zucchi R, Accorroni A, Chiellini G. Zucchi R, et al. Front Physiol. 2014 Oct 16;5:402. doi: 10.3389/fphys.2014.00402. eCollection 2014. Front Physiol. 2014. PMID: 25360120 Free PMC article. Review.

6

Thyronamines and Analogues - The Route from Rediscovery to Translational Research on Thyronergic Amines.

Chiellini G, Bellusci L, Sabatini M, Zucchi R. Chiellini G, et al. Among authors: zucchi r. Mol Cell Endocrinol. 2017 Dec 15;458:149-155. doi: 10.1016/j.mce.2017.01.002. Epub 2017 Jan 6. Mol Cell Endocrinol. 2017. PMID: 28069535 Review.

7

Recovery of 3-Iodothyronamine and Derivatives in Biological Matrixes: Problems and Pitfalls.

Lorenzini L, Ghelardoni S, Saba A, Sacripanti G, Chiellini G, Zucchi R. Lorenzini L, et al. Among authors: zucchi r. Thyroid. 2017 Oct;27(10):1323-1331. doi: 10.1089/thy.2017.0111. Thyroid. 2017. PMID: 28859548

8

Cardiac effects of thyronamines.

Zucchi R, Ghelardoni S, Chiellini G. Zucchi R, et al. Heart Fail Rev. 2010 Mar;15(2):171-6. doi: 10.1007/s10741-008-9120-z. Epub 2008 Nov 19. Heart Fail Rev. 2010. PMID: 19016324 Review.

9

Tissue distribution and cardiac metabolism of 3-iodothyronamine.

Saba A, Chiellini G, Frascarelli S, Marchini M, Ghelardoni S, Raffaelli A, Tonacchera M, Vitti P, Scanlan TS, Zucchi R. Saba A, et al. Among authors: zucchi r. Endocrinology. 2010 Oct;151(10):5063-73. doi: 10.1210/en.2010-0491. Epub 2010 Aug 25. Endocrinology. 2010. PMID: 20739399

10

Modulation of gene expression by 3-iodothyronamine: genetic evidence for a lipolytic pattern.

Mariotti V, Melissari E, Iofrida C, Righi M, Di Russo M, Donzelli R, Saba A, Frascarelli S, Chiellini G, Zucchi R, Pellegrini S. Mariotti V, et al. Among authors: zucchi r. PLoS One. 2014 Nov 7;9(11):e106923. doi: 10.1371/journal.pone.0106923. eCollection 2014. PLoS One. 2014. PMID: 25379707 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

230 results

Search Page